Arthritis is the leading cause of disability in adults in the U.S. Understandably, this has led to much concern about the future of arthritis treatment.
Age-related muscle loss, called sarcopenia, happens to all of us as we age and is a major cause of disability and loss of independence in the elderly.
OMRF scientist Holly Van Remmen has been named president-elect of the Society for Redox Biology and Medicine.
OMRF scientist Bumsoo Ahn, Ph.D., has been awarded an Irene Diamond Fund/AFAR Postdoctoral Transition Award in Aging.
An OMRF discovery could potentially open the door for the first drug option to treat age-related muscle weakness and atrophy.
The trio of scientists assumed their new positions at the foundation Nov. 1, bringing the total number of OMRF senior scientists to 49.